CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- S-3ASR Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Code of ethics change
- 4 Shares withheld for taxes CEO & President gave up 43,165 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 22,094 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 26,835 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 13,470 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,511 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 17,096 shares (to pay taxes)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
Page 8 of 28 · 557 filings